Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia
Sameem M. Abedin
Guru Subramanian Guru Murthy
Mehdi Hamadani
Laura C. Michaelis
Karen-Sue Carlson
Lyndsey Runaas
Katelyn Gauger
Avinash G. Desai
Mary M. Chen
Kate L. Li
Mojisola Rotibi
Umar Syed
Madhuri Vusirikala
Alexandra Harrington
Ehab L. Atallah
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1038/s41375-025-02528-3
Feb 15, 2025
Version published to 10.21203/rs.3.rs-5368989/v1 on Research Square
Dec 1, 2024
Related articles
Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: Results of a first-in-human Phase 1 trial
This article has 9 authors:
Jong Chul PARK
Brendan Curti
Marcus Butler
Joseph Elassal
Robert Tighe
Sailaja Battula
Gail Iodice
Howard Kaufman
John Kirkwood
Maveropepimut-S, Pembrolizumab and Low-dose Cyclophosphamide in Patients with Metastatic Ovarian Cancer: Final Results from Phase 1/2 PESCO trial
This article has 16 authors:
Amit Oza
Ana Veneziani
Stephanie Lheureux
Douglas Millar
Neesha Dhani
Ilaria Colombo
Ainhoa Madariaga
Pamela Soberanis
Swati Atale
Yin-Ling Chan
Joshua Lee
Janelle Ramsahai
Judy Quintos
Lisa Wang
Valerie Bowering
Pamela Ohashi
Avapritinib monotherapy induces rapid and deep remission of heavily treated, KIT D816H-mutated t(8;21) acute myeloid leukemia
This article has 4 authors:
Ted M. Getz
Kamila Bakirhan
Stuart Seropian
Rory M. Shallis
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up